Autoantibodies to a 38-kDa glycosylated islet cell membrane-associated antigen in (pre)type 1 diabetes: Association with IA-2 and islet cell autoantibodies

Diabetes Care

Volumn 24, Issue 7, 2001, Pages 1181-1186

  Winnock, Frederic ^a   Christie, Michael R ^b   Batstra, Manou R ^c   Aanstoot, Henk Jan ^c   Weets, Ilse ^a   Decochez, Katelijn ^a   Jopart, Philippe ^d   Nicolaij, Dany ^e   Gorus, Frans K ^a,f  

^a DIABETES RESEARCH CENTER   (Belgium)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^d Hospital de Jolimont   (Belgium)

^e OLV HOSPITAL   (Belgium)

^f VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; GLUTAMATE DECARBOXYLASE; HLA DQ ANTIGEN; ICA512 AUTOANTIBODY; PANCREAS ISLET CELL ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; BELGIUM; BLOOD; CHILD; COMPARATIVE STUDY; FEMALE; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; GLYCOSYLATION; HUMAN; IMMUNOLOGY; IMPAIRED GLUCOSE TOLERANCE; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NUCLEAR FAMILY; PANCREAS ISLET; PREDICTION AND FORECASTING; PRESCHOOL CHILD; REGISTER; SEXUAL DEVELOPMENT;

ADOLESCENT; ADULT; AUTOANTIBODIES; BELGIUM; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; GENOTYPE; GLUTAMATE DECARBOXYLASE; GLYCOSYLATION; HLA-DQ ANTIGENS; HUMANS; INFANT; ISLETS OF LANGERHANS; MALE; NUCLEAR FAMILY; POLYMORPHISM, GENETIC; PREDIABETIC STATE; PREDICTIVE VALUE OF TESTS; REGISTRIES; SEX CHARACTERISTICS;

EID: 0035403063     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.24.7.1181     Document Type: Article

References (20)

1. Aanstoot HJ, Kang SM, Kim J, Lindsay LA, Roll U, Knip M, Atkinson M, Mose-Larsen P, Fey S, Ludvigsson J, Landin M, Bruining J, Maclaren N, Åkerblom HK, Baekkeskov S: Identification and characterization of glima 38, a glycosylated islet cell membrane antigen, which together with GAD65 and IA-2 marks the early phases of autoimmune response in type 1 diabetes. J Clin Invest 97:2772-2783, 1996
2. Roll U, Turck CW, Gitelman SE, Rosenthal SM, Nolte MS, Masharani U, Ziegler AG, Baekkeskov S: Peptide mapping and characterisation of glycation patterns of the glima 38 antigen recognised by autoantibodies in type 1 diabetic patients. Diabetologia 43:598-608, 2000
3. Gorus FK, the Belgian Diabetes Registry: Diabetes registries and early biological markers of insulin-dependent diabetes mellitus. Diabete Metab Rev 13:247-274, 1997
4. Slover RH, Eisenbarth GS: Prevention of type I diabetes and recurrent beta-cell destruction of transplanted islets. Endocr Rev 18:241-258, 1997
5. Bingley PJ, Bonifacio E, Gale EA: Can we really predict IDDM? (Review) Diabetes 42:213-220, 1993
6. Todd JA: Genetic analysis of type 1 diabetes using whole genome approaches. Proc Natl Acad Sci U S A 92:8560-8565, 1995
7. Vandewalle CL, Coeckelberghs MI, De Leeuw IH, Du Caju MV, Schuit FC, Pipeleers DG, Gorus FK, the Belgian Diabetes Registry: Epidemiology, clinical aspects, and biology of IDDM patients under age 40 years: comparison of data from Antwerp with complete ascertainment with data from Belgium with 40% ascertainment. Diabetes Care 20:1556-1561, 1997
8. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039-1057, 1979
9. Christie MR, Hollands JA, Brown TJ, Michelsen BK, Delovitch TL: Detection of pancreatic islet 64,000 Mr autoantigens in insulin-dependent diabetes distinct from glutamate decarboxylase. J Clin Invest 92:240-248, 1993
10. Baekkeskov S, Aanstoot HJ, Christgau S, Reetz A, Solimena M, Cascalho M, Folli F, Richter-Olesen H, DeCamilli P: Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 347:151-156, 1990
11. Vandewalle CL, Decraene T, Schuit FC, De Leeuw IH, Pipeleers DG, Gorus FK, the Belgian Diabetes Registry: Insulin autoantibodies and high titre islet cell antibodies are preferentially associated with the HLA DQA1*0301-DQB1*0302 haplotype at clinical onset of type 1 (insulin-dependent) diabetes mellitus before age 10 years, but not at onset between age 10 and 40 years. Diabetologia 36:1155-1162, 1993
12. Decochez K, Tits J, Coolens J-L, Van Gaal L, Krzentowski G, Winnock F, Anckaert E, Weets I, Pipeleers DG, Gorus FK, the Belgian Diabetes Registry: High frequency of persisting or increasing islet-specific autoantibody levels after diagnosis of type 1 diabetes presenting before 40 years of age. Diabetes Care 23:838-844, 2000
13. Verge CF, Stenger D, Bonifacio E, Colman PG, Pilcher C, Bingley PJ, Eisenbarth GS: Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop. Diabetes 47:1857-1866, 1998
14. Van der Auwera B, Schuit F, Lyaruu I, Falorni A, Svanholm S, Vandewalle CL, Gorus FK, the Belgian Diabetes Registry: Genetic susceptibility for insulin-dependent diabetes mellitus in Caucasians revisited: the importance of diabetes registries in disclosing interactions between HLA-DQ- and insulin gene-linked risk. J Clin Endocrinol Metab 80:2567-2573, 1995
15. Payton MA, Hawkes CJ, Christie MR: Relationship of the 37,000- and 40,000-Mr tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512). J Clin Invest 96:1506-1511, 1995
16. Hatfield ECI, Hawkes CJ, Payton MA, Christie MR: Cross reactivity between IA-2 and phogrin/IA-2β in binding of autoantibodies in IDDM. Diabetologia 40:1327-1333, 1997
17. Verge CF, Gianani R, Kawasaki E, Yu L, Pietropaolo M, Jackson RA, Chase HP, Eisenbarth GS: Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 45:926-933, 1996
18. Gorus FK, Goubert P, Semakula C, Vandewalle CL, De Schepper J, Scheen A, Christie MR, Pipeleers DG, the Belgian Diabetes Registry: IA-2-autoantibodies complement GAD65-autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings. Diabetologia 40:95-99, 1997
19. Kulmala P, Savola K, Petersen JS, Vahasalo P, Karjalainen J, Lopponen T, Dyrberg T, Å kerblom HK, Knip M: Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes: a population-based study. The Childhood Diabetes in Finland Study Group. J Clin Invest 101:327-36, 1998
20. Bonifacio E, Bingley PJ, Shattock M, Dean BM, Dunger D, Gale EA, Bottazzo GF: Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes. Lancet 335:147-149, 1990